search
Back to results

Integrated Patient Care Intradialysis Programme in Hemodialysis Through a Virtual Health Platform (GoodRENal)

Primary Purpose

End Stage Renal Disease, Hemodialysis-Induced Symptom, Chronic Kidney Diseases

Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Virtual reality health platform during hemodialysis
Sponsored by
Cardenal Herrera University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for End Stage Renal Disease focused on measuring exercise, physical function, health related quality of life, nutrition, psychological wellbeing

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients on hemodialysis medically stable
  • Ability to walk to walk at least a few steps, even if walking aids like canes or a walker ar needed
  • Life expectancy greater than 6 months

Exclusion Criteria:

  • Myocardial infarction in the previous 6 weeks
  • Angina unstable on exercise or at rest
  • Brain injury derived from a cardiovascular problem. Cerebral vascular disease such as stroke in the last 6 months or with relevant sequelae in lower limb mobility presenting hemiparesia.
  • Life expectancy less than 6 months
  • Cognitive impairment
  • Language barriers
  • Illiteracy

Sites / Locations

  • KU Leuven
  • Aristotle University of ThessalonikiRecruiting
  • Hospital de ManisesRecruiting
  • Universitat de Valencia
  • Universitat Politécnica de Valéncia
  • Skane Univeristy Hospital
  • Karolinska Institute

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Virtual reality health platform during hemodialysis

Control group-usual care

Arm Description

During 12 weeks subjects will use a VR platform during hemodialysis. The intervention will be virtual reality exercise, nutritional advice and psychological wellbeing support plus cognitive training.

During 12 weeks subjects will carry on with the usual care in the hemodialysis unit

Outcomes

Primary Outcome Measures

Change from baseline distance walked assessed by the 6 minutes walk test at 12 weeks
More meters walked in 6 minutes mean a better walking capacity

Secondary Outcome Measures

Change from baseline health-related quality of life assessed by the Short Form 36 questionnaire at 12 weeks
The short form 36 gives data on 8 subscales and 2 components, higher score mean better health-related quality of life The scores range from 0 to 100, with 100 indicating optimal health and 0 reflecting very poor health.
Change from baseline stance from a chair capacity assessed by the sit to stand 10 at 12 weeks
Time in seconds to perform 10 sit to stand repetitions. A decrease in the time to perform the test means better functional capacity to stand up from a chair
Change from baseline usual gait speed assessed by a 4 meters gait speed test at 12 weeks
Speed in m/s to cover 4 meters at normal speed. An increase in speed to perform the test means better gait speed
Change from baseline handgrip strength assessed by a handgrip dinamometer at 12 weeks
Bilateral handgrip strength measured in kilograms. An increase in handgrip strength means better strength
Change from baseline lower limbs strength assessed by a dinamometer at 12 weeks
Bilateral lower limbs muscle strength measured in kilograms. An increase in strength means better strength
Change from baseline physical activity level assessed by the human activity profile questionnaire, average activity score at 12 weeks
The average activity score of the human activity profile questionnaire ranges from 0 to 94. . A higher score means a higher physical activity level
Change from baseline physical activity level assessed by the international physical activity questionnaire at 12 weeks
The score of the international physical activity questionnaire will be recorded in MET-minutes/week. A higher score means a higher physical activity level
Percentage of sessions performed from te sessions offered to measure adherence to the educational program
Calculation will be the result of sessions performed/sessions offered
Healthcare resources expenditure and costs
Total amount in euros spent on external consultations, laboratory tests, radiology tests, hospital pharmacy, emergency department healthcare provision, and hospitalisation.
Change from baseline lean body mass assessed by the bioimpedance spectroscopy at 12 weeks
Lean body mass is a surrogate of muscle mass in kilograms. Increase in lean body mass means increase in muscle mass
Change from baseline qualitative assessment in food intake assessed by the Short form food questionnaire at 12 weeks
Qualitative assessment of food intake Short form food questionnaire. Improvement in the dietary quality
Change from baseline nutritional status assessed by the 7 point Subjective Global Assessment at 12 weeks
7 point subjective global assessment scores from 1 to 7, the higher the score the better nutritional status
Change from baseline cognitive function assessed by the Mini-mental State at 12 weeks
The maximum MMSE score is 30 points. A score of 20 to 24 suggests mild dementia, 13 to 20 suggests moderate dementia, and less than 12 indicates severe dementia.
Change from baseline Anxiety assessed by the Hospital Anxiety and Depression Scale at 12 weeks
Scores obtained between 0 and 21. The higher the score obtained, the higher the level of anxiety and depression.
Change from baseline positive and negative emotions assessed by Positive and Negative Affect Schedule Scale (PANAS) at 12 weeks
It includes 2 subscales (positive affect and negative affect) with 10 items each. Each subscale can contain scores between 10 and 50. The higher the score obtained, the greater the presence of a particular affect.
Change from baseline depression assessed by the Beck Depression Inventory (BDI) at 12 weeks
The scores range from 0 to 63 points. The higher the score, the greater the severity of depressive symptoms. Four groups are established according to the total score: 0-13, minimal depression; 14-19, mild depression; 20-28, moderate depression; and 29-63, severe depression.
Change from baseline anxiety assessed by the State Trait Anxiety Inventory (STAI) at 12 weeks
Scale composed of 2 subscales. The range of scores for both subscales is between 0 and 60 points so that higher scores reflect greater anxiety.
Change from baseline perceived stress assessed by the Perceived Stress Scale (PSS) at 12 weeks
Scores obtained in a range of 0 to 56 points. The higher the score obtained, the higher the level of perceived stress.
Change from baseline cognitive state assessed by the Montreal Cognitive Assessment (MoCA)at 12 weeks
Scores on the MoCA assessment range from 0 to 30. A score of 26 and above is considered normal.
Change from baseline attention level assessed by the Trail Making Test (TMT) at 12 weeks
Scoring is based on time taken to complete the test, with lower scores being better.
Change from baseline memory assessed by the Wechsler-IV Memory Scale at 12 weeks
The correction system allows obtaining scalar scores, indices, centiles and confidence intervals, in order to achieve a more flexible interpretation. It is interpreted on the basis of scales. The Spanish scales have been elaborated from a sample of almost 900 subjects aged between16 and 90 years.

Full Information

First Posted
January 28, 2021
Last Updated
February 10, 2023
Sponsor
Cardenal Herrera University
Collaborators
Hospital de Manises, Universitat Politècnica de València, University of Valencia, Karolinska Institutet, Skane University Hospital, KU Leuven, Aristotle University Of Thessaloniki
search

1. Study Identification

Unique Protocol Identification Number
NCT04823286
Brief Title
Integrated Patient Care Intradialysis Programme in Hemodialysis Through a Virtual Health Platform
Acronym
GoodRENal
Official Title
REVID +: Integrated Patient Care Intradialysis Programme in Hemodialysis Through a Virtual Health Platform (GoodRENal.eu)
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 31, 2021 (Actual)
Primary Completion Date
July 31, 2023 (Anticipated)
Study Completion Date
August 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cardenal Herrera University
Collaborators
Hospital de Manises, Universitat Politècnica de València, University of Valencia, Karolinska Institutet, Skane University Hospital, KU Leuven, Aristotle University Of Thessaloniki

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
There is wide evidence regarding the weak points of end-stage Chronic kidney disease (CKD) patients in hemodialysis, and they include three intervention aspects: exercise, nutrition and psychological support. Evidence shows that exercise for patients in hemodialysis results in increased survival rate, functional capacity, strength and health-related quality of life. Additionally, different studies have shown the benefits of psychological interventions and the positive effect of educational programs on nutritional care for patients in hemodialysis. Despite the well-known benefits of exercise, this kind of programs are not being implemented in the routine clinical care of hemodialysis patients. Thus, the GoodRENal project aims to promote healthy lifestyles among dialysis patients in a holistic approach that combines exercise, nutrition and psychological wellbeing plus cognitive functioning addressing adult learners. The project will, in phase 1, explore barriers and facilitators of patients, carers and health professionals towards healthy lifestyle (physical activity, nutrition and psychological well being). In phase 2, the project will develop a health virtual platform including these three dimensions of cares. In summary, the project outputs will be: A didactic content in a modular platform to create an educational program for integrated treatments in patients with dialysis A guideline to promote healthy lifestyles among dialysis patients for health care providers A guideline to promote e healthy lifestyles among dialysis patients for patients and formal - nonformal carers
Detailed Description
CKD stage 5D, has a high incidence, 100-200 people per million, and high prevalence, 750-1500 per million. More than 40-50% are above 65 years old, with a lower rate in women but with higher frailty than men. This cohort presents high comorbidity, malnutrition, sedentary behavior, low health-related quality of life, frailty and high dependency levels. Mortality risk is close to 15% per year. Cardiovascular disease is the main cause of death in end-stage CKD. It is also a high risk factor for peripheral artery disease and lower limbs amputation. Supporting this cohort results in high direct and indirect costs. Additionally, these patients present high anxiety and depression rates. Comorbidity between depression and somatic illness leads to a significant increase of the illness load since there is higher symptomatology, higher morbidity, higher health costs, and worse functioning and quality of life. Current evidence suggests a bidirectional relationship between depression and medical illness. Mechanisms suggested explaining this complex relationship would include both biological and behavioral aspects. Depression is also associated with the worst adherence to treatment of comorbid patients. There is wide evidence regarding the weak points of end-stage CKD patients in hemodialysis, and they include three intervention aspects: exercise, nutrition and psychological support. Evidence shows that exercise for patients in hemodialysis results in increased survival rate, functional capacity, strength, and health-related quality of life. Additionally, different studies have shown the benefits of psychological interventions and the positive effect of educational programs on nutritional care for patients in hemodialysis. Several combined interventions have been implemented leading to heterogeneous results. Despite the well-known benefits of exercise, this kind of programs are not being implemented in the routine clinical care of hemodialysis patients. Patients' lack of interest regarding participation in exercise programs, time constraints, and lack of knowledge by health professionals at the hemodialysis units, are some of the factors underpinning the low implementation rate of intradialysis exercise programs. Virtual reality (VR) refers to computer-generated interactive simulation that offers users the opportunity to participate in environments that look like objects and events of the real world. VR exercise has been successfully implemented in neuro-rehabilitation, resulting in better balance, gait, and mobility in cerebrovascular accidents, multiple sclerosis, Guillain-Barre syndrome, and Parkinson's disease. Few studies have explored the impact of VR exercise in renal rehabilitation. Three of the partners (Universidad Cardenal Herrera-CEU, Universitat Politècnica de Valéncia, and Hospital de Manises) have implemented two randomized trials of non-immersive VR exercise intradialysis. Currently, those partners are developing a third trial with this technology and they have verified that this type of exercise has good tolerance and high adherence rates. Additionally, it has a positive impact on strength, functional capacity, physical activity level, and health-related quality of life. Until now, the most traditional way to assess and implement psychological and psycho-educative treatments has been 'face to face'. Nevertheless, more than 50% of people suffering from depression are not being treated appropriately. This is why alternative treatment models to assess and treat are being implemented, and technology (as the internet) is an option to increase the number of patients that can be treated. Additionally, few studies have explored technology as a means to educate renal patients regarding nutrition or psychological health. Thus, the hypothesis of the present study is that a health virtual platform designed for holistic treatment of patients undertaking hemodialysis will result in health benefits for this cohort, regarding physical activity, nutritional and psychological health. The platform will be designed according to the aims highlighted by experts, barriers, and needs of end-stage CKD patients and their caregivers. As mentioned above, end-stage chronic kidney disease patients have high comorbidity, malnutrition, sedentarism, low health-related quality of life, low physical function, frailty, and high dependency levels. So they rely on non-formal caregivers for their activities of daily living. This cohort presents high anxiety and depression levels and the combination of somatic disease plus depression results in higher symptoms, higher comorbidity, higher health resources, and worst quality of life. Besides, there is a bidirectional relationship between depression and disease, and depression is associated with lower adherence to medical treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
End Stage Renal Disease, Hemodialysis-Induced Symptom, Chronic Kidney Diseases
Keywords
exercise, physical function, health related quality of life, nutrition, psychological wellbeing

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants will be randomized into one of two groups, intradialysis virtual reality platform or usual care
Masking
InvestigatorOutcomes Assessor
Masking Description
A team of assessors, different to the researchers implementing the exercise, will record all dependent variables. A blind researcher will randomize participants
Allocation
Randomized
Enrollment
108 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Virtual reality health platform during hemodialysis
Arm Type
Experimental
Arm Description
During 12 weeks subjects will use a VR platform during hemodialysis. The intervention will be virtual reality exercise, nutritional advice and psychological wellbeing support plus cognitive training.
Arm Title
Control group-usual care
Arm Type
No Intervention
Arm Description
During 12 weeks subjects will carry on with the usual care in the hemodialysis unit
Intervention Type
Other
Intervention Name(s)
Virtual reality health platform during hemodialysis
Intervention Description
Subjects will play a virtual reality game specially adapted for subjects undertaking hemodialysis. The game will also aim at providing nutritional advice, and improving psychological wellbeing and cognitive function.
Primary Outcome Measure Information:
Title
Change from baseline distance walked assessed by the 6 minutes walk test at 12 weeks
Description
More meters walked in 6 minutes mean a better walking capacity
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Secondary Outcome Measure Information:
Title
Change from baseline health-related quality of life assessed by the Short Form 36 questionnaire at 12 weeks
Description
The short form 36 gives data on 8 subscales and 2 components, higher score mean better health-related quality of life The scores range from 0 to 100, with 100 indicating optimal health and 0 reflecting very poor health.
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline stance from a chair capacity assessed by the sit to stand 10 at 12 weeks
Description
Time in seconds to perform 10 sit to stand repetitions. A decrease in the time to perform the test means better functional capacity to stand up from a chair
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline usual gait speed assessed by a 4 meters gait speed test at 12 weeks
Description
Speed in m/s to cover 4 meters at normal speed. An increase in speed to perform the test means better gait speed
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline handgrip strength assessed by a handgrip dinamometer at 12 weeks
Description
Bilateral handgrip strength measured in kilograms. An increase in handgrip strength means better strength
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline lower limbs strength assessed by a dinamometer at 12 weeks
Description
Bilateral lower limbs muscle strength measured in kilograms. An increase in strength means better strength
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline physical activity level assessed by the human activity profile questionnaire, average activity score at 12 weeks
Description
The average activity score of the human activity profile questionnaire ranges from 0 to 94. . A higher score means a higher physical activity level
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline physical activity level assessed by the international physical activity questionnaire at 12 weeks
Description
The score of the international physical activity questionnaire will be recorded in MET-minutes/week. A higher score means a higher physical activity level
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Percentage of sessions performed from te sessions offered to measure adherence to the educational program
Description
Calculation will be the result of sessions performed/sessions offered
Time Frame
After 12 weeks of intervention
Title
Healthcare resources expenditure and costs
Description
Total amount in euros spent on external consultations, laboratory tests, radiology tests, hospital pharmacy, emergency department healthcare provision, and hospitalisation.
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline lean body mass assessed by the bioimpedance spectroscopy at 12 weeks
Description
Lean body mass is a surrogate of muscle mass in kilograms. Increase in lean body mass means increase in muscle mass
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline qualitative assessment in food intake assessed by the Short form food questionnaire at 12 weeks
Description
Qualitative assessment of food intake Short form food questionnaire. Improvement in the dietary quality
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline nutritional status assessed by the 7 point Subjective Global Assessment at 12 weeks
Description
7 point subjective global assessment scores from 1 to 7, the higher the score the better nutritional status
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline cognitive function assessed by the Mini-mental State at 12 weeks
Description
The maximum MMSE score is 30 points. A score of 20 to 24 suggests mild dementia, 13 to 20 suggests moderate dementia, and less than 12 indicates severe dementia.
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline Anxiety assessed by the Hospital Anxiety and Depression Scale at 12 weeks
Description
Scores obtained between 0 and 21. The higher the score obtained, the higher the level of anxiety and depression.
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline positive and negative emotions assessed by Positive and Negative Affect Schedule Scale (PANAS) at 12 weeks
Description
It includes 2 subscales (positive affect and negative affect) with 10 items each. Each subscale can contain scores between 10 and 50. The higher the score obtained, the greater the presence of a particular affect.
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline depression assessed by the Beck Depression Inventory (BDI) at 12 weeks
Description
The scores range from 0 to 63 points. The higher the score, the greater the severity of depressive symptoms. Four groups are established according to the total score: 0-13, minimal depression; 14-19, mild depression; 20-28, moderate depression; and 29-63, severe depression.
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline anxiety assessed by the State Trait Anxiety Inventory (STAI) at 12 weeks
Description
Scale composed of 2 subscales. The range of scores for both subscales is between 0 and 60 points so that higher scores reflect greater anxiety.
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline perceived stress assessed by the Perceived Stress Scale (PSS) at 12 weeks
Description
Scores obtained in a range of 0 to 56 points. The higher the score obtained, the higher the level of perceived stress.
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline cognitive state assessed by the Montreal Cognitive Assessment (MoCA)at 12 weeks
Description
Scores on the MoCA assessment range from 0 to 30. A score of 26 and above is considered normal.
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline attention level assessed by the Trail Making Test (TMT) at 12 weeks
Description
Scoring is based on time taken to complete the test, with lower scores being better.
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
Title
Change from baseline memory assessed by the Wechsler-IV Memory Scale at 12 weeks
Description
The correction system allows obtaining scalar scores, indices, centiles and confidence intervals, in order to achieve a more flexible interpretation. It is interpreted on the basis of scales. The Spanish scales have been elaborated from a sample of almost 900 subjects aged between16 and 90 years.
Time Frame
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients on hemodialysis medically stable Ability to walk to walk at least a few steps, even if walking aids like canes or a walker ar needed Life expectancy greater than 6 months Exclusion Criteria: Myocardial infarction in the previous 6 weeks Angina unstable on exercise or at rest Brain injury derived from a cardiovascular problem. Cerebral vascular disease such as stroke in the last 6 months or with relevant sequelae in lower limb mobility presenting hemiparesia. Life expectancy less than 6 months Cognitive impairment Language barriers Illiteracy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Eva SEGURA-ORTÍ, PhD
Phone
00 34 671580094
Email
eva.segura@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eva SEGURA-ORTÍ
Organizational Affiliation
Universidad CEU Cardenal Herrera, UCH CEU
Official's Role
Principal Investigator
Facility Information:
Facility Name
KU Leuven
City
Leuven
ZIP/Postal Code
3000
Country
Belgium
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amaryllis H Van Craenenbroeck, PhD
Email
Amaryllis.vancraenenbroeck@kuleuven.be
Facility Name
Aristotle University of Thessaloniki
City
Thessaloníki
ZIP/Postal Code
57001
Country
Greece
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Evangelia Kouidi, PhD
Email
kouidi@phed.auth.gr
Facility Name
Hospital de Manises
City
Manises
State/Province
Valencia
ZIP/Postal Code
46940
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eva SEGURA-ORTÍ, PhD
Phone
00 34 671580094
Email
eva.segura@gmail.com
Facility Name
Universitat de Valencia
City
Valencia
ZIP/Postal Code
46010
Country
Spain
Individual Site Status
Enrolling by invitation
Facility Name
Universitat Politécnica de Valéncia
City
Valencia
ZIP/Postal Code
46022
Country
Spain
Individual Site Status
Enrolling by invitation
Facility Name
Skane Univeristy Hospital
City
Lund
Country
Sweden
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Naomi Clyne, PhD
Email
Naomi.Clyne@med.lu.se
Facility Name
Karolinska Institute
City
Stockholm
ZIP/Postal Code
14186
Country
Sweden
Individual Site Status
Enrolling by invitation

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
28114792
Citation
Segura-Orti E, Gordon PL, Doyle JW, Johansen KL. Correlates of Physical Functioning and Performance Across the Spectrum of Kidney Function. Clin Nurs Res. 2018 Jun;27(5):579-596. doi: 10.1177/1054773816689282. Epub 2017 Jan 23.
Results Reference
background
PubMed Identifier
21719637
Citation
Segura-Orti E, Martinez-Olmos FJ. Test-retest reliability and minimal detectable change scores for sit-to-stand-to-sit tests, the six-minute walk test, the one-leg heel-rise test, and handgrip strength in people undergoing hemodialysis. Phys Ther. 2011 Aug;91(8):1244-52. doi: 10.2522/ptj.20100141. Epub 2011 Jun 30.
Results Reference
background
PubMed Identifier
20701722
Citation
Segura-Orti E, Johansen KL. Exercise in end-stage renal disease. Semin Dial. 2010 Jul-Aug;23(4):422-30. doi: 10.1111/j.1525-139X.2010.00766.x.
Results Reference
background
PubMed Identifier
20098466
Citation
Segura-Orti E. [Exercise in haemodyalisis patients: a literature systematic review]. Nefrologia. 2010;30(2):236-46. doi: 10.3265/Nefrologia.pre2010.Jan.10229. Epub 2010 Jan 21. Spanish.
Results Reference
background
PubMed Identifier
19473613
Citation
Segura-Orti E, Kouidi E, Lison JF. Effect of resistance exercise during hemodialysis on physical function and quality of life: randomized controlled trial. Clin Nephrol. 2009 May;71(5):527-37. doi: 10.5414/cnp71527.
Results Reference
background
PubMed Identifier
18336134
Citation
Segura-Orti E, Rodilla-Alama V, Lison JF. [Physiotherapy during hemodialysis: results of a progressive resistance-training programme]. Nefrologia. 2008;28(1):67-72. Spanish.
Results Reference
background

Learn more about this trial

Integrated Patient Care Intradialysis Programme in Hemodialysis Through a Virtual Health Platform

We'll reach out to this number within 24 hrs